Danshensu Attenuates Palmitic Acid-Induced Activation of Hepatic Stellate Cells by Regulating Pyroptosis
International Journal of Medical Sciences · 2025
DOI: 10.7150/ijms.107564 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Han-Fang Tseng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Taichung Veterans General Hospital, Taichung 407, Taiwan. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Pyroptosis, Lactates, Palmitic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
We focused on examining the role of Danshensu in reducing reactive oxygen species (ROS) production and inhibiting NLRP3 inflammasome activation, which are key factors in liver fibrosis and inflammation. We sought to explore the potential of Danshensu as a therapeutic agent for liver fibrosis by targeting the pyroptosis-inflammasome signaling pathway, providing a basis for developing effective and safer NLRP3 inflammasome inhibitors. This study aimed to investigate whether Danshensu can mitigate palmitic acid (PA)-induced activation of hepatic stellate cells (HSCs) by regulating pyroptosis in HSC-T6 and LX-2 cells.
Methods
HSC-T6 and LX-2 cell lines served as the cell models. A 2',7'-dichlorofluorescin diacetate reagent was used to measure ROS production within cells. Cell protein extraction was performed using radioimmunoprecipitation assay lysis buffer. The protein concentration in each sample was measured using a BCA assay kit. Western blot analysis was used with the SDS-polyacrylamide gel electrophoresis system.
Results
PA-induced activation of HSC-T6 and LX-2 cells by upregulating alpha-smooth muscle actin, integrin-β1, and connective tissue growth factor. Danshensu mitigated PA-induced ROS accumulation in these cells. Moreover, Danshensu potentially reversed the upregulation of NLRP3, cleaved caspase 1, interleukin-1, GSDME, and ASC in PA-activated LX-2 cells via pyroptosis, suggesting its therapeutic potential. Pyroptosis inhibitor tetramethylthiuram disulfide reversed Danshensu attenuated PA activation of HSC-T6 and LX-2 cells, resulting in a 2-fold increase in alpha-smooth muscle actin, integrin-β1, and connective tissue growth factor.
Conclusion
Danshensu effectively attenuates PA-induced HSC activation by reducing ROS production and inhibiting pyroptosis, offering a potential therapeutic strategy for liver fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Taichung Veterans General Hospital, Taichung 407, Taiwan.
- Department of Nephrology, Hanming Christian Hospital, Changhua City 500, Taiwan.
- Department of Internal Medicine, Cathay General Hospital, Taipei 106, Taiwan.
- School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City 242, Taiwan.
- Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan.
- Department of Nursing, Cardinal Tien College of Healthcare and Management, New Taipei City 231, Taiwan.
Zitieren
APA
Tseng, H. F., Chao, H. N., Lin, C. H., & Kuo, C. Y. (2025). Danshensu Attenuates Palmitic Acid-Induced Activation of Hepatic Stellate Cells by Regulating Pyroptosis. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.107564
Vancouver
Tseng HF, Chao HN, Lin CH, Kuo CY. Danshensu Attenuates Palmitic Acid-Induced Activation of Hepatic Stellate Cells by Regulating Pyroptosis. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.107564
BibTeX
@article{Tseng2025,
author = {Tseng, Han-Fang and Chao, Huan-Nung and Lin, Chih-Hung and Kuo, Chan-Yen},
title = {Danshensu Attenuates Palmitic Acid-Induced Activation of Hepatic Stellate Cells by Regulating Pyroptosis},
journal = {International Journal of Medical Sciences},
year = {2025},
doi = {10.7150/ijms.107564}
}
EUVIMED